Search results for "Highlights"

Results 41 - 50 of about 379 for "Highlights".
Sort by: Relevance | Newest | Oldest

Statins associated with progression of diabetes

A retrospective study of veterans with diabetes found that those who started statin therapy were more likely to meet criteria for diabetes progression, such as initiation of insulin or an additional antihyperglycemic drug class, over time.
8 Oct 2021

Type 1 and type 2 diabetes associated with increased risk of herpes zoster

Results of a systematic review and meta-analysis were consistent across age groups, diabetes types, and regions of the world. The study authors suggested that earlier vaccination against herpes zoster in all patients with diabetes, regardless of age, be considered.
8 Oct 2021

No differences seen in outcomes with one-step vs. two-step gestational diabetes screening

The one-step screening process, which used a two-hour fasting glucose tolerance test, found more cases of gestational diabetes in a randomized trial, but perinatal and maternal complications did not differ.
12 Mar 2021

Choice of SGLT-2 inhibitors, GLP-1 receptor agonists should be based on individual risk

A meta-analysis comparing sodium-glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists found differing effects, including that the SGLT-2 inhibitors affected heart failure outcomes while GLP-1 receptor agonists reduced stroke risk.
12 Feb 2021

Recent KDIGO guideline focused on patients with diabetes and kidney disease

A new summary of the guideline from Kidney Disease: Improving Global Outcomes (KDIGO) highlights important points for clinicians, including recommendations about prescribing of diabetes medications.
13 Nov 2020

Physician-patient discussions may decrease unnecessary self-monitoring of blood glucose levels

In a cross-sectional survey at an Ohio health system, 67% of respondents with non-insulin-controlled type 2 diabetes said they monitored their blood glucose levels because their physician had asked them to, and 50% said they would stop if given permission.
10 Sep 2021

GLP-1 receptor agonists improved cardiovascular, kidney outcomes in type 2 diabetes

In a systematic review and meta-analysis of eight randomized controlled trials, glucagon-like peptide-1 (GLP-1) receptor agonists reduced major adverse cardiovascular events by 14%, all-cause mortality by 12%, hospital admission for heart failure by 11%, and a composite kidney outcome by 21%, with no increase in safety outcomes.
10 Sep 2021

Antidepressant adherence linked to lower risk of advanced complications of diabetes

In patients with diabetes and depression in Taiwan, regular use of an antidepressant was associated with a 0.92-fold decreased risk of macrovascular complications and a 0.86-fold decreased risk of all-cause mortality compared with poor adherence.
13 Aug 2021

Diets with low glycemic index or glycemic load may benefit patients with diabetes

A systematic review and meta-analysis found small improvements in established targets for glycemic control, blood lipids, adiposity, and inflammation among those with moderately controlled type 1 and type 2 disease who tried low glycemic index/load diets.
13 Aug 2021

PPIs may have beneficial glycemic effects in patients with diabetes

A systematic review and meta-analysis found that proton-pump inhibitors (PPIs) improved glycemic indices in patients with diabetes and did not appear to affect risk for incident diabetes.
9 Jul 2021

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next